✦ LIBER ✦

BepreveTM 1.5% Provides Clinically Meaningful Reduction in Allergen-Induced Ocular Itching for Subjects in an Analysis of Two Phase 3 Conjunctival Allergen Challenge (CAC) Clinical Trials

✍ Scribed by Williams, J.I.; Schooley, G.L.; Gow, J.A.; McNamara, T.R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BepreveTM 1.5% Reduces Rhinorrhea for at

✍ McNamara, T.R.; Williams, J.I.; Gow, J.A.; Gomes, P.J.; Abelson, M.A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

BepreveTM 1.5% Reduces Nasal Congestion

✍ Gow, J.A.; Williams, J.I.; McNamara, T.R.; Gomes, P.J.; Abelson, M.B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB